21 May 2013
Keywords: ipsen, inamed, start, ph, ii, botulinum, toxin
Article | 13 January 2003
Beaufour Ipsen of France has started a Phase II trial of its botulinumtoxin type A for use in aesthetic medicine ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 June 2003
22 July 2002
19 May 2003
© 2013 thepharmaletter.com